News and Trends 2 Jan 2017
Fresh Cash for a Device that Can Treat Diabetes and Prevent HIV
Intarcia will develop a drug delivery device for HIV prevention that can significantly reduce dosing frequency, backed by a €134M…
HIV
- Latest Posts
Best in Biotech 22 Dec 2016
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
What are the most impressive advances in medical biotechnology this year? From cancer to peanut allergy, here's a list of…
News and Trends 20 Dec 2016
These are our 10 Most Read Biotech Articles of 2016
From the hottest research areas to the most popular city for biotech, which biotech articles have managed to hook our readers…
News and Trends 12 Dec 2016
With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy
Seeking to disrupt the NGS market, Oxford Nanopore is rolling in cash. Before we heard the news, we sat down…
ADVERTISEMENT
News and Trends 5 Dec 2016
Video: Chatting with Immunocore about the Potential of Immuno-oncology
At Refresh in Paris, I had the opportunity to ask Eva-Lotta Allan,CBO of one of Europe's hottest companies, Immunocore, some…
News and Trends 1 Dec 2016
UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa
Update (01/12/2016): The HVTN 702 trial has been started, making it the first HIV vaccine efficacy study in 7 years…
News and Trends 1 Dec 2016
It’s World AIDS Day, is Biotech close to an HIV Cure?
Biotech is working hard on developing an HIV cure, as well as fast diagnostics and vaccines. For those living with the disease,…
News and Trends 21 Nov 2016
One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?
A new hope for HIV: a single antibody that can target nearly all viral strains at once. What does it…
News and Trends 14 Nov 2016
USB key Diagnostic could help manage HIV Treatment Anywhere
A new method of gene sequencing has brought us an HIV diagnostic on a "USB stick", which determines the levels…
News and Trends 10 Nov 2016
This has been the Worst Financial Year for Biotech in a Decade
A presentation on the financial state of biotech kicked off BIO-Europe in Cologne this week. The hostile American political climate…
News and Trends 9 Nov 2016
Up, up and away! CureVac’s money pile now Totals €325M
CureVac has raised an additional €27M ($29.5M) that will help the company keep on its track to be the first…
News and Trends 4 Oct 2016
One Step Closer to an HIV Cure That Can Eliminate the Latent Virus
HIV has completely disappeared from the blood of a patient in clinical trials. The new HIV treatment that can target the virus even…
News and Trends 3 Oct 2016
Researchers Find New Weak Spots to Develop an HIV Cure
Last week we published a thorough review on current approaches for an HIV cure, which may be available as soon as 2020.…
News and Trends 29 Sep 2016
Interview: This Biotech Could Have the First HIV Cure on the Market
InnaVirVax is one of the most advanced companies in the race to develop an HIV cure. At the SACHS Conference…
News and Trends 1 Sep 2016
GSK is Advancing a Revolutionary Dual HIV Therapy
Gilead has long been the leader in HIV treatments, but GlaxoSmithKline's CEO revealed to the WSJ that the company has…
News and Trends 24 Aug 2016
While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’
Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen to unprecedented levels in Europe.…
ADVERTISEMENT
News and Trends 15 Aug 2016
Gilead licenses Danish Bispecific antibodies for the next HIV Cure
As an add-on to their previously secretive partnership, Genmab is now licensing its bispecific antibodies for Gilead's pursuit of an HIV…
News and Trends 12 Jul 2016
How did Helen Lee overcome barriers to HIV Diagnostics in the ‘Real World’?
How can diagnostics be improved in resource limited settings? And how can the practical limitations of transporting heat-sensitive assay material…
News and Trends 11 Jul 2016
On the way to a ‘Functional’ HIV Cure? Norway Vaccine clears viral load in 88% of Patients
Oslo based Biopharma Bionor has a Phase I results for a HIV vaccine. The vaccine infusion rendered viral presence in…
News and Trends 4 Jul 2016
“We have one of the World’s Most Advanced Functional HIV Cures under development”
Abivax has recently announced that it's likely that its most advanced program in hepatitis B will fail its Phase III trials.…
